Binah Capital Group, Inc. BCG
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -62.50%
- 1 year
- -31.65%
- Open
- 1.11
- Prev close
- 1.08
- Mkt cap
- 18.42M
- Vol
- 16.76K
- Avg vol
- 33.87K
- EPS
- 0.14
- P/E
- 7.71
- Div yield
- 0.00%
More statistics
- Low
- 1.06
- High
- 1.15
- Forward P/E
- 0.00
- Beta
- 0.46
- Short ratio
- 3.42
- Inst. own
- 0.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.55
- 200-d avg
- 4.58
- 1y target
- 0.00
News
1 week ago gurufocus.com
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
Landmark results from the DeLLphi-305 Phase III trial showed IMFINZIÂ (durvalumab) plus Amgen's tarlatamab-dlle demonstrated a statistically significant and hi
1 week ago gurufocus.com
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca's IMFINZIÂ (durvalumab) in combination with neoadjuvant enfortu
1 week ago gurufocus.com
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced detailed positive recurrence-free surv
2 weeks ago businesswire.com
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the…
2 weeks ago defenseworld.net
Binah Capital Group, Inc. (NASDAQ:BCG) Stock Short Interest Report for September
Binah Capital Group, Inc. (NASDAQ: BCG - Get Free Report) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totaling 2,413…
3 weeks ago defenseworld.net
Head-To-Head Comparison: Binah Capital Group (NASDAQ:BCG) versus Hennessy Advisors (NASDAQ:HNNA)
Binah Capital Group (NASDAQ: BCG - Get Free Report) and Hennessy Advisors (NASDAQ: HNNA - Get Free Report) are both small-cap finance companies, but which is the superior business? We will compare…
1 month ago defenseworld.net
Binah Capital Group (NASDAQ:BCG) and PennantPark Investment (NASDAQ:PNNT) Financial Survey
PennantPark Investment (NASDAQ: PNNT - Get Free Report) and Binah Capital Group (NASDAQ: BCG - Get Free Report) are both small-cap finance companies, but which is the superior investment? We will…
1 month ago gurufocus.com
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
1 month ago businesswire.com
New ABB and BCG Report Highlights Growing Role of Direct Current Technologies in Future Power Systems
ZURICH--(BUSINESS WIRE)--ABB today published a new report, The Strategic Case for Hybrid AC/DC Power: Shaping the Transition to the Next Electrical Architecture, developed in collaboration with…
1 month ago gurufocus.com
New ABB and BCG report highlights growing role of direct current technologies in future power systems
New ABB and BCG report highlights growing role of direct current technologies in future power systems PR Newswire
2 months ago globenewswire.com
Binah Capital Group Reports Results for Second Quarter of 2026
- Assets Under Management (“AuM”) Increased 13.4% Year-over-Year to $31.6 Billion - - Increased Net Income to $0.3 Million from a net loss of $(0.7) million in the Prior Year Period - - Increased…
2 months ago globenewswire.com
Binah Capital Group to Participate in Sidoti Micro-Cap Virtual Conference August 19-20
NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Binah Capital Group, Inc. (“Binah”, “Binah Capital” or the “Company”) (NASDAQ: BCG; BCGWW), a leading financial services enterprise that owns and operates…
3 months ago youtube.com
BCG CEO: AI adoption now as high on CEOs' agenda as profits
Christoph Schweizer, CEO of Boston Consulting Group (BCG), tells CNBC's Squawk Box Europe that AI adoption is now as much on the minds of global CEOs as sales and profits, as businesses begin to…
4 months ago gurufocus.com
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
4 months ago businesswire.com
81% of Enterprises Report AI Initiatives Delayed, Scaled Back, or Abandoned Due to Data Permission and Governance Gaps, Finds Transcend Research
SAN FRANCISCO--(BUSINESS WIRE)--Transcend, the autonomous "can I use this data?" platform that powers every data decision to scale customer growth, released The 2026 State of Customer Data in the…
5 months ago gurufocus.com
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
5 months ago gurufocus.com
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the
5 months ago businesswire.com
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca's IMFINZI® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the…
5 months ago gurufocus.com
TVS Motor Company Ranked #1 Globally For Shareholder Value Creation In 'Durable Consumer Goods' By WirtschaftsWoche And Boston Consulting Group
TVS Motor Company, part of TVS VENU, has been ranked #1 globally in the âDurable Consumer Goods' category in the annual âBest Stocks in the World', ranking
5 months ago gurufocus.com
ImmunityBio Announces FDA Acceptance of Supplemental BLA for ANKTIVA® Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Papillary Disease; PDUFA Date Set for January 6, 2027
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration has accepte
7 months ago benzinga.com
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.
7 months ago benzinga.com
Binah Capital Group (BCG) Stock Surges 59% After Hours — Here's Why
Binah Capital surged 59.20% in after-hours trading on strong fourth-quarter and full-year results, posting profitability and double-digit revenue growth.
-
7 months ago benzinga.com
Binah Capital Group Q4 EPS $0.01 Up From $(0.07) YoY, Sales $50.512M Up From $44.608M YoY
Binah Capital Group (NASDAQ:BCG) reported quarterly earnings of $0.01 per share. This is a 114.29 percent increase over losses of $(0.07) per share from the same period last year. The company…
-
11 months ago benzinga.com
Market-Moving News for November 14th
BNO, USO: ~1.5% | Oil is trading higher amid reports of Iran seizing an oil tanker in the Strait of Hormuz as well as reports of a Ukrainian drone strike on Russia's Novorossiysk port. This news has…
11 months ago benzinga.com
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
11 months ago benzinga.com
Why Binah Capital (BCG) Stock Jumped 75% In After-Hours Trading
Binah Capital jumped 74.76% in after-hours trading following stronger-than-expected Q3 results.
-
11 months ago benzinga.com
Binah Capital Group Q3 EPS $0.08 Up From $(0.09) YoY, Sales $46.198M Up From $42.197M YoY
Binah Capital Group (NASDAQ:BCG) reported quarterly earnings of $0.08 per share. This is a 188.89 percent increase over losses of $(0.09) per share from the same period last year. The company…
-
2 years ago benzinga.com
12 Financials Stocks Moving In Monday's Intraday Session
12 Financials Stocks Moving In Monday's Intraday Session
-
2 years ago benzinga.com
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
-
2 years ago benzinga.com
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.